Eric Easom
CEO, AN2 Therapeutics, Inc.
Companies#
| Company | Role | World rank | Market cap | Since Jan 2024 |
|---|---|---|---|---|
| AN2 Therapeutics, Inc.🇺🇸 | CEO | #16,784 | $172 M | -70.2% |
Eric Easom's share trades#
Shares Eric Easom reported buying, selling or receiving on SEC Form 4 as an insider: $115 K bought and $1.6 M sold on the open market in all.
| Traded | Company | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Grant or award | +112,250 | — | — | 368,630 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Buy | +10,000 | $1.070 | $11 K | 256,380 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Grant or award | +145,250 | — | — | 246,380 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Buyindirect | +50,000 | $1.000 | $50 K | 1.07 M | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Grant or awardamended | +99,000 | — | — | 101,130 | Form 4/A |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Grant or award | +99,000 | — | — | 101,130 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -2,777 | $20.09 | $56 K | 2,130 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Buyindirect | +10,000 | $5.380 | $54 K | 1.02 M | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -23 | $15.04 | $346 | 4,907 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -4,413 | $15.32 | $68 K | 4,930 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -10,111 | $15.61 | $158 K | 4,907 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -5,800 | $15.41 | $89 K | 16,273 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -1,255 | $16.38 | $21 K | 15,018 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -10,167 | $15.90 | $162 K | 6,943 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -2,036 | $16.72 | $34 K | 4,907 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -8,828 | $15.80 | $139 K | 17,110 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -11,082 | $15.67 | $174 K | 29,021 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -3,083 | $16.02 | $49 K | 25,938 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -1,544 | $15.07 | $23 K | 4,907 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -2,688 | $15.39 | $41 K | 6,451 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -1,683 | $15.09 | $25 K | 4,907 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -924 | $15.36 | $14 K | 6,590 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -1,678 | $15.10 | $25 K | 4,907 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -4,272 | $15.69 | $67 K | 7,119 | Form 4 |
| filed | 🇺🇸 AN2 Therapeutics, Inc.ANTX | Sell10b5-1 plan | -534 | $16.20 | $9 K | 6,585 | Form 4 |